Jennewein Biotechnologie

Management

Jennewein Biotechnologie – an industrial biotechnology company

The Jennewein Biotechnologie is an industrial biotechnology company, which manufactures mono- and oligosaccharides. Of particular interest is here the production of high quality oligosaccharides with his application in the food and pharmaceutical sector.

 

From left to right: Stephan Michel, Dr. Stefan Jennewein, Glyn Brookman, Dr. Benedikt Engels

From left to right: Stephan Michel, Dr. Stefan Jennewein, Glyn Brookman, Dr. Benedikt Engels

Dr. Stefan Jennewein studied Biochemistry, Pharmacology and Organic Chemistry at the Universities of Sussex (Brighton, UK), Zurich (CH), Tübingen (D) and Cambridge (UK), and at the Ludwig-Maximilians-Universität (Munich, D). Dr. Stefan Jennewein also gained practical experience through his work at Washington State University (Pullman, USA), the company DSM N.V. (Delft, NL), the Technical University of Darmstadt (D), and the Fraunhofer Institute for Molecular Biology and Applied Ecology (Aachen, D). Dr. Stefan Jennewein is the Managing Director for research and development, regulatory issues, and quality management at Jennewein Biotechnologie.

Stephan Michel studied Business Administration in Bielefeld and Düsseldorf. He gained practical experience through his work as an audit manager at KPMG before, at the beginning of 2002, he moved to the Holding of the Karstadt-Quelle enterprise in Essen. There he established and developed the Services Subgroup and directed the bookkeeping of the Holding company, who had more than 5000  employees and total assets of 1,3 billion. Subsequently he worked as CFO at the medium-sized IT service company  EDS ITelium GmbH and later as CFO Europe at the Reutax group in Heidelberg.

Since 2013 until summer 2016 he works as Managing Director for the Pawlowsky Consultancy GmbH, who have for the first time, established daily updated reportings on a Group level. Since the beginning of 2016  he first was resonsible at Jennewein Biotechnologie GmbH  on a interim basis for the human resources and finance division before he has assumed in August 2016 the position as CFO.

Glyn Brookman started his business life at the NatWest Bank International training Center in Kings Cross, London UK, as an office Junior. From there he moved to a higher position within the bank as an accounting support clerk, and then on to the stock broking arm of County NatWest Stockbrokers as a member of the support staff to the Broker floor, where he gained valuable experience in the London financial markets. He then moved into the world of money Broking where he worked as a Sterling Money Broker, at Butler Harlow Ueda Ltd. next to London Bridge.

Glyn Brookman moved to Germany in February of 1995 and took up the roll of Key Account Manager and then Group leader of the Automotive arm of Maxim Integrated Products. Since spring 2016 he is Director Sales and Authorized Officer at the Jennewein Biotechnologie GmbH.

Dr. rer. nat. Benedikt Engels studied Bioengineering at the University of Applied Science, Division Jülich. Subsequently he worked as a scientific employee at the Department of Industrial Biotechnology at the Fraunhofer Institute for Molecular Biology and Applied Ecology in Aachen, where he received his PhD. After a period as Postdoc at the Fraunhofer Institute he joined Jennewein Biotechnologie GmbH in July 2014 as Head of Analytics in the Department of Research and Development. Since spring 2016 he has assumed the position of Head of Production and Authorized Officer at the Jennewein Biotechnologie GmbH.